Wang L - Search Results

1

Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.

Wang L, Shi WY, Wu ZY, Varna M, Wang AH, Zhou L, Chen L, Shen ZX, Lu H, Zhao WL, Janin A. Wang L, et al. Among authors: wang ah. J Hematol Oncol. 2010 Sep 9;3:30. doi: 10.1186/1756-8722-3-30. J Hematol Oncol. 2010. PMID: 20828385 Free PMC article.

2

Proteasome inhibitor bortezomib targeted tumor-endothelial cell interaction in T-cell leukemia/lymphoma.

Shi WY, Wang L, Xiao D, Yao Y, Yang F, Jiang XX, Leboeuf C, Janin A, Chen SJ, Zhao WL. Shi WY, et al. Among authors: wang l. Ann Hematol. 2011 Jan;90(1):53-8. doi: 10.1007/s00277-010-1022-1. Epub 2010 Jul 9. Ann Hematol. 2011. PMID: 20617436

3

Rituximab plus CHOP (R-CHOP) overcomes PRDM1-associated resistance to chemotherapy in patients with diffuse large B-cell lymphoma.

Liu YY, Leboeuf C, Shi JY, Li JM, Wang L, Shen Y, Garcia JF, Shen ZX, Chen Z, Janin A, Chen SJ, Zhao WL. Liu YY, et al. Among authors: wang l. Blood. 2007 Jul 1;110(1):339-44. doi: 10.1182/blood-2006-09-049189. Epub 2007 Mar 22. Blood. 2007. PMID: 17379744 Free article.

4

PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor.

Zhao WL, Liu YY, Zhang QL, Wang L, Leboeuf C, Zhang YW, Ma J, Garcia JF, Song YP, Li JM, Shen ZX, Chen Z, Janin A, Chen SJ. Zhao WL, et al. Among authors: wang l. Blood. 2008 Apr 1;111(7):3867-71. doi: 10.1182/blood-2007-08-108654. Epub 2008 Jan 30. Blood. 2008. PMID: 18235046 Free article.

5

[Analysis of overexpression of vascular endothelial growth factor-C in patients with angioimmunoblastic T-cell lymphoma].

Zhao WL, Liu YY, Plassa F, Jin XL, Wang L, Janin A, Shen ZX. Zhao WL, et al. Among authors: wang l. Zhonghua Xue Ye Xue Za Zhi. 2007 Oct;28(10):664-6. Zhonghua Xue Ye Xue Za Zhi. 2007. PMID: 18399170 Chinese.

6

[Efficacy and safety of imatinib in treatment of 151 chronic myeloid leukemia patients].

Zhou L, Wang AH, Wang L, You JH, Li JM, Shen ZX. Zhou L, et al. Among authors: wang l, wang ah. Zhonghua Xue Ye Xue Za Zhi. 2008 Jan;29(1):13-7. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 18512309 Chinese.

7

Summary of 615 patients of chronic myeloid leukemia in Shanghai from 2001 to 2006.

Wang AH, Wang YY, Yao Y, Xu ZZ, Zhou L, Wang L, Zhang L, Chen Y, Shen ZX, Hu J, Li JM. Wang AH, et al. Among authors: wang yy, wang l. J Exp Clin Cancer Res. 2010 Mar 3;29(1):20. doi: 10.1186/1756-9966-29-20. J Exp Clin Cancer Res. 2010. PMID: 20199658 Free PMC article.

8

[Nilotinib treatment for imatinib resistant or intolerant chronic myelogenous leukemia.].

Wang AH, Zhou L, You JH, Wang L, Li JM, Hu J, Shen ZX. Wang AH, et al. Among authors: wang l. Zhonghua Xue Ye Xue Za Zhi. 2010 Jan;31(1):11-5. Zhonghua Xue Ye Xue Za Zhi. 2010. PMID: 20302768 Chinese.

9

Bevacizumab potentiates chemotherapeutic effect on T-leukemia/lymphoma cells by direct action on tumor endothelial cells.

Wang L, Shi WY, Yang F, Tang W, Gapihan G, Varna M, Shen ZX, Chen SJ, Leboeuf C, Janin A, Zhao WL. Wang L, et al. Haematologica. 2011 Jun;96(6):927-31. doi: 10.3324/haematol.2010.037689. Epub 2011 Feb 17. Haematologica. 2011. PMID: 21330328 Free PMC article.

10

Prognostic factors of Chinese patients with T/NK-cell lymphoma: a single institution study of 170 patients.

Xu PP, Wang Y, Shen Y, Wang L, Shen ZX, Zhao WL. Xu PP, et al. Among authors: wang l, wang y. Med Oncol. 2012 Sep;29(3):2176-82. doi: 10.1007/s12032-011-0011-0. Epub 2011 Jun 28. Med Oncol. 2012. PMID: 21710236

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146,449 results

Search Page

Filters